Simplexvirus – Talk Bio

Assembly Bio Reports Phase 1b Success in Herpes; Gilead Increases Stake with 2.3M Shares

1 month ago talkbio0Tagged ABI-5366, Assembly (construction), Bio, Collaboration, genital lesion reduction, Gilead Sciences, herpesvirus 2, human, safety profile, Simplexvirus, stock purchase, viral shedding

Assembly Bio; Phase 1b trial; ABI-5366; herpes simplex virus (HSV-2); viral shedding reduction; genital lesion reduction; safety profile; Gilead Sciences; collaboration; stock purchase

GSK’s Therapeutic Herpes Vaccine Fails to Meet Efficacy Objective in Phase I/II Trial

12 months ago talkbio0Tagged Clinical Trials, Failure (biologic function), Herpes Simplex Infections, Simplexvirus, SmithKline Beecham, Vaccines

GSK, therapeutic herpes vaccine, herpes simplex virus, HSV, vaccine failure, clinical trial

GSK Abandons HSV Vaccine Development After Phase 2 Failure, Paving Way for Moderna and BioNTech

12 months ago talkbio0Tagged BioNTech, HSV vaccine, Moderna, RNA, Messenger, Simplexvirus, SmithKline Beecham

GSK, HSV vaccine, phase 2 failure, Moderna, BioNTech, mRNA vaccines, herpes simplex virus